MedTrace Logo

Observational Prospective Study With Probiotic Supplementation on Infants With FGDI

NCT04944628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-06-29

No results posted yet for this study

Summary

This observational prospective study evaluates the safety, tolerability and efficacy of a probiotic formula in infants with functional gastrointestinal disorders (FGDI)

Conditions

  • Functional Gastrointestinal Disorders
  • Infantile Colic
  • Functional Constipation

Interventions

DIETARY_SUPPLEMENT

Probiotic

Probiotic in liquid format (oil suspension) administered 10 drops once daily for 2 weeks (2x10\^9 cfu/day)

Sponsors & Collaborators

  • AB Biotics, SA

    lead INDUSTRY

Principal Investigators

  • Maura Sticco, MD · Azienda Sanitaria Locale Napoli

Eligibility

Min Age
1 Month
Max Age
10 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2018-12-05
Completion
2018-12-05

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04944628 on ClinicalTrials.gov